Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
Get Adobe Flash player

Video: OxyContin's phase out Add to ...

Dr. David Juurlink, head of clinical pharmacology and toxicology at Sunnybrook, explains how the OxyNEO compares to OxyContin

Drive

Technology

In the know

More from The Globe and Mail

Most popular stories